tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SUPN Stock Latest News

Supernus Provides Regulatory Update for SPN-830
Press ReleasesSupernus Provides Regulatory Update for SPN-830
11d ago
SUPN
Supernus: FDA says SPN-830 NDA ‘not ready for approval’ in present form
PremiumThe Fly
Supernus: FDA says SPN-830 NDA ‘not ready for approval’ in present form
11d ago
SUPN
Supernus to Participate in Two Upcoming Investor Conferences
PremiumPress Releases
Supernus to Participate in Two Upcoming Investor Conferences
1M ago
SUPN
Supernus Pharmaceuticals Enhances Executive Compensation Packages
PremiumCompany Announcements
Supernus Pharmaceuticals Enhances Executive Compensation Packages
2M ago
8K
SUPN
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
PremiumPress Releases
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
2M ago
SUPN
Supernus price target lowered to $41 from $45 at Piper Sandler
PremiumThe FlySupernus price target lowered to $41 from $45 at Piper Sandler
2M ago
SUPN
Supernus sees 2024 revenue $580M-$620M, consensus $622.52M
PremiumThe Fly
Supernus sees 2024 revenue $580M-$620M, consensus $622.52M
2M ago
SUPN
Supernus reports Q4 EPS 2c, consensus 40c
PremiumThe Fly
Supernus reports Q4 EPS 2c, consensus 40c
2M ago
SUPN
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
2M ago
SUPN
Supernus Pharmaceuticals (SUPN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Supernus Pharmaceuticals (SUPN) Q4 Earnings Cheat Sheet
2M ago
SUPN
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024
PremiumPress Releases
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024
2M ago
SUPN
Supernus Pharmaceuticals Wins Patent Infringement Lawsuit
PremiumCompany Announcements
Supernus Pharmaceuticals Wins Patent Infringement Lawsuit
2M ago
8K
SUPN
Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
PremiumPress ReleasesSupernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
2M ago
SUPN
Supernus wins infringement, validity case on Trokendi XR against Torrent
PremiumThe Fly
Supernus wins infringement, validity case on Trokendi XR against Torrent
2M ago
SUPN
Knight Therapeutics enters into exclusive license agreement with Supernus
PremiumThe Fly
Knight Therapeutics enters into exclusive license agreement with Supernus
4M ago
SUPN
Supernus narrows FY23 revenue view to $590M-$610M from $580M-$620M
PremiumThe Fly
Supernus narrows FY23 revenue view to $590M-$610M from $580M-$620M
5M ago
SUPN
Supernus reports Q3 GAAP EPS (29c), consensus 13c
PremiumThe Fly
Supernus reports Q3 GAAP EPS (29c), consensus 13c
5M ago
SUPN
Supernus Announces Third Quarter 2023 Financial Results
PremiumPress Releases
Supernus Announces Third Quarter 2023 Financial Results
5M ago
SUPN
Supernus to Participate in the Jefferies London Healthcare Conference
PremiumPress Releases
Supernus to Participate in the Jefferies London Healthcare Conference
5M ago
SUPN
Supernus Pharmaceuticals (SUPN) Q3 Earnings Cheat Sheet
PremiumPre-EarningsSupernus Pharmaceuticals (SUPN) Q3 Earnings Cheat Sheet
6M ago
SUPN
Supernus announces SPN-830 NDA accepted for review by FDA
PremiumThe Fly
Supernus announces SPN-830 NDA accepted for review by FDA
6M ago
SUPN
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
PremiumPress Releases
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
6M ago
SUPN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >